This eBook's collection of articles focuses on exciting developments in the field of cell therapy and many important considerations that can help you accelerate and achieve your cell therapy program goals.
In this eBook, sponsored by Isoplexis, we highlight recent studies in which IsoPlexis’ immune profiling delivered key omic insights had the potential to accelerate curative medicines.
In this eBook, sponsored by Precision for Medicine, we have brought together best practices and leading-edge developments in the industry to help researchers optimize sourcing, utilization, and storage of biospecimens as they move their research and development programs forward.
In this eBook, sponsored by Sartorius, we highlight the research efforts and related applications utilized to study binding affinity, potency and target specificities of neutralizing antibodies against SARS-CoV-2 and their potential for future use against diseases caused by viruses from the same coronavirus subgroup.
The number of cell and gene therapies (CGTs) entering clinical development has increased significantly in recent years. However, the surge in clinical activity has not been matched by an increase in production capacity. Cytiva's collection of articles focuses on the need for making crucial decisions early in process development in order to minimize risk, cost, product variability and time to market.
In this article Thermo Fisher Scientific provides information on how to simplify workflows and maximize the efficiency of the mRNA purification process with POROS™ Oligo (dT)25 affinity resin.
In this eBook see how IsoPlexis’ multifaceted functional proteomics platform enables single-cell secreted proteomics, low-volume highly multiplexed proteomics from serum, single-cell phosphoprotein analysis, and single-cell metabolomic analysis all on one integrated, benchtop system, making functional proteomics accessible to virtually every lab worldwide.
In this new GEN eBook sponsored by Thermo Fisher Scientific, we will explore various aspects of AAV bioproduction—looking at the challenges that many investigators face, and some of the novel solutions others have employed when ramping up viral production. Additionally, you can learn how new technology like AI is allowing researchers to use AAV in exciting new ways.
This eBook, sponsored by Thermo Fisher Scientific, introduces the steps to take when choosing a perfusion medium, including key considerations and evaluation, along with articles highlighting the exciting potential of large-scale continuous bioprocesses.
In this eBook, sponsored by Origene, you will read about the fascinatingways bioengineering has changed how antibodymolecules are applied to research and the clinicalworld. Despite all the changes, specificity remainsthe core value determinant of an antibody, albeitnaturally or recombinantly made.